SMPD1 and anterior segment dysgenesis: The reduced levels of CB1 observed in ASM‐KO neurons, especially evident in the neuronal processes, and the reported ability of this receptor to activate NSM and hydrolyze SM in astrocytes (Sanchez et al, 2001) prompted us to assess the therapeutic potential of enhancing eCB action in ASMD.